Diabetes drugs called GLP-1 agonists might help calm body-wide inflammation and improve how well the heart relaxes, especially in people with a type of heart failure where the heart pumps fine but doesn’t fill properly.

GLP-1 drugs shrink a layer of fat that surrounds the heart — this fat is linked to heart disease, and shrinking it may help protect the heart from damage.

GLP-1 drugs are changing the game for treating obesity because they help people lose more weight and improve heart and metabolic health better than older treatments.

If you're an adult with type 2 diabetes and obesity, taking diabetes drugs like semaglutide or dulaglutide might quickly shrink the fat around your heart—especially if you take a higher dose—and that could help calm down harmful inflammation nearby.

GLP-1 drugs don’t just lower blood sugar — they also make dangerous artery plaques more stable by reducing inflammation and strengthening the plaque’s outer shell, which helps prevent heart attacks and strokes.

Losing weight by turning on a specific brain and gut signal (GLP-1) can help improve health problems linked to obesity, like high blood sugar or high blood pressure.